Log In
Print this Print this

Tedopi (OSE 2101) (formerly EP-2101, EP2101, IDM-2101, Texopi)

  Manage Alerts
Collapse Summary General Information
Company Orphan Synergy Europe Pharma S.A.
DescriptionVaccine containing 10 modified epitopes plus the PADRE universal helper T lymphocyte epitope targeting 5 tumor-associated antigens (TAA)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today